In this analysis, researchers used the 7-year follow-up results of a phase 3 trial to evaluate the long-term outcomes of CCRT with S-1 compared to radiotherapy alone in older esophageal cancer ...
Tisotumab vedotin plus carboplatin and pembrolizumab improved survival outcomes in patients with recurrent/metastatic cervical cancer.
Nearly a third of physician practices are using AI scribes and others are working to add AI as a tool to cut down on administrative work.
In this retrospective cohort study, researchers aimed to evaluate long-term trends in subsequent primary cancer risk among US cancer survivors.
Researchers developed and validated a new lung cancer prediction model, Sybil-Epi, by integrating clinical and epidemiologic data with a pre-existing model.
(HealthDay News) — A blood test for circulating tumor human papillomavirus DNA (ctHPVDNA) may improve risk assessment in patients undergoing surgery for HPV-related oropharyngeal cancer, according to ...
The effect of tumor necrosis factor–alpha inhibitor exposure on skin cancer risk among patients with inflammatory diseases was examined.
Five-year overall and lung cancer-specific survival rates were similar for octogenarians and younger patients.
Data from the SISTER study show that 1:1 peer support significantly increases the odds that Black women with endometrial cancer will complete treatment, according to research pres ...
Survivors of nearly all types of adolescent and young adult cancer have an increased risk for developing a subsequent primary neoplasm, according to a study published online April 13 in CMAJ, the ...
Researchers found that 51% of cervical cancer clinical trials excluded all individuals living with HIV. Individuals living ...
Abemaciclib plus letrozole shows clinically meaningful activity in patients with advanced or recurrent endometrioid endometrial cancer in a phase 2 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results